Walmart and Care Access to Open Three New Clinical Trial Centers to Expand Access to Medical Research
Walmart Healthcare Research Institute and Care Access to Open Three New Clinical Trial Centers in 2027 Walmart Healthcare Research Institute (WHRI) and Care Access have announced plans to expand their…
Monebo and Innolitics Obtain FDA 510(k) Clearance for Cross-Platform ECG Arrhythmia Analysis Software Library
Monebo Technologies and Innolitics Secure FDA 510(k) Clearance for Kinetic ECG Analysis Software Library Monebo Technologies, Inc. and Innolitics have announced that the U.S. Food and Drug Administration (FDA) has…
REDEMPLO® (Plozasiran) Offers New Triglyceride-Lowering Treatment Option for Adults with FCS in England and Wales
Arrowhead Pharmaceuticals’ REDEMPLO Gains NICE Recommendation for NHS Treatment of Familial Chylomicronaemia Syndrome in England and Wales Arrowhead Pharmaceuticals’ REDEMPLO® (plozasiran) has received a positive funding recommendation from the National…
Avanzanite Bioscience Strengthens UK Operations with Appointment of Sarah O’Connell as Country Manager
Avanzanite Bioscience Expands UK Operations, Appoints Sarah O’Connell as Country Manager to Strengthen Rare Disease Medicine Access Avanzanite Bioscience B.V., a European pharmaceutical company specializing in rare diseases, has announced…
Laxxon Medical Names Matthew Cascio Vice President and Head of Business Development
Laxxon Medical Appoints Matthew Cascio as Vice President and Head of Business Development to Drive Strategic Partnerships Laxxon Medical has announced the appointment of Matthew Cascio as Vice President and…
Powerful Medical Secures CPT Code for AI-Powered Heart Attack Detection Following FDA Authorization of Queen of Hearts™
Powerful Medical Secures New CPT Code for Queen of Hearts AI ECG Technology to Detect Heart Attacks Powerful Medical, a company specializing in artificial intelligence (AI)-driven cardiovascular diagnostics, has announced…
Rumi Therapeutics Licenses IND-Ready PDE2 Inhibitor RTX-7340 to Enthorin Therapeutics for Fragile X Syndrome Development
Rumi Therapeutics Secures Option to License Enthorin’s IND-Ready PDE2 Inhibitor for Fragile X Syndrome Rumi Therapeutics, a drug-development company operating within Rumi Scientific Holdings, has announced an option-to-license agreement with…
Sacituzumab Tirumotecan Cuts Death Risk by 32% and Disease Progression Risk by 41% in Advanced Endometrial Cancer
Merck’s Sacituzumab Tirumotecan Cuts Risk of Death by 32% in Advanced Endometrial Cancer in Phase 3 TroFuse-005 Trial Merck, known as MSD outside the United States and Canada, has announced…
Incyte Presents New Data Advancing Gastrointestinal Cancer Pipeline at ESMO 2026
Incyte Presents Updated Clinical Data for KRAS G12D and TGFβR2×PD-1 Programs in Pancreatic and Colorectal Cancers Incyte has announced new clinical findings from its expanding oncology portfolio, highlighting the potential…
Dong-A ST Highlights Preclinical Potential of Topical Icotrokinra for Psoriasis Treatment
Dong-A ST Presents Preclinical Findings Supporting Topical Icotrokinra Development for Psoriasis Dong-A ST Co., Ltd., a South Korean pharmaceutical company led by President and CEO Jae-hoon Jeong, has presented preclinical…
Align Technology Pledges Additional $1 Million to Support Future Orthodontic Educators and Leaders
Align Technology Commits $1 Million to AAO Foundation to Support Future Orthodontic Educators Align Technology, Inc., a global medical device company specializing in digital orthodontics and restorative dentistry, has announced…
NaphCare Advances Correctional Healthcare Technology at Annual TechCare User Group
NaphCare to Host Annual TechCare User Group to Advance Correctional Healthcare Technology and Innovation NaphCare, a provider of healthcare services for correctional facilities, will bring together correctional healthcare partners from…